Quick Facts
| Peptide name | Thymulin |
|---|---|
| Research category | Immunity |
| Molecular formula | C₃₃H₅₄N₁₂O₁₅ (peptide moiety) |
| Molecular weight | ≈ 857 g/mol (peptide, excluding bound zinc) |
| Sequence | Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn (zinc-dependent nonapeptide) |
| Primary research interest | Zinc-dependent thymic immune regulation and neuroendocrine signaling |
| Storage considerations | Lyophilized powder stored frozen at −20 °C, kept dry and dark; reconstituted solution refrigerated at 2–8 °C and protected from light. |
| Solubility notes | Water-soluble; biological activity depends on coordination with zinc, so research framing emphasizes the zinc–peptide complex (FTS-Zn). |
| Related compounds | Thymosin Alpha-1, Thymalin, LL-37, VIP |
Introduction
Research Use Only
Thymulin is discussed here strictly as an investigational research compound for educational and laboratory reference. It is not guidance for human use, diagnosis, treatment, or prevention of disease.
Thymulin — historically known as facteur thymique sérique (FTS) — is a nonapeptide produced by the thymic epithelium, and it is distinctive for being biologically active only when bound to zinc. It belongs to the family of thymic peptides that researchers study for their role in shaping the immune system, and it is frequently examined alongside Thymosin Alpha-1, another well-characterized thymic immunomodulatory peptide.
The conceptual appeal of thymulin research is its position at the crossroads of immunology and endocrinology. The thymus is where T-lymphocytes mature, and thymulin output declines with age as the gland involutes. Because its activity depends on zinc — a nutrient itself tied to immune competence — thymulin is studied as a molecule connecting trace-element status, thymic function, and immune regulation.
This profile covers what thymulin is, its zinc-dependent structure, its mechanism in T-cell biology, the immune and neuroendocrine research it appears in, and how it compares with related thymic and immune peptides. Related entries are catalogued in the peptide database.
What is Thymulin?
Thymulin is a nine-amino-acid peptide secreted by the thymic epithelial cells. Its peptide sequence alone is biologically inactive; activity appears only when the peptide coordinates a zinc ion, forming the active complex often written FTS-Zn. This obligatory metal dependence is the single most defining feature of thymulin and sets it apart from most other peptides in this library.
Because zinc availability governs how much active thymulin is present, the molecule serves in research as a sensitive readout of the interplay between trace-element nutrition and immune function. Studies have noted that circulating active thymulin falls with zinc deficiency and with the age-related shrinkage of the thymus, and that restoring zinc can be associated with recovered thymulin activity in research models.
At a glance
Class: zinc-dependent thymic nonapeptide (FTS / FTS-Zn). Source: thymic epithelial cells. Defining feature: requires bound zinc for activity. Research focus: T-cell differentiation and immune/neuroendocrine regulation.
Molecular and structural characteristics
Thymulin's peptide backbone is a short, hydrophilic nonapeptide (Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn). The functionally critical element is its zinc-binding site: the metal ion induces the conformation required for receptor engagement and biological activity. Apo-thymulin (zinc-free) and holo-thymulin (zinc-bound) are therefore treated as distinct entities in the literature.
Because the molecule is small and lacks an extensive folded structure, its specificity derives from side-chain chemistry organized around the zinc center rather than from a large protein fold. This makes thymulin straightforward to synthesize but means research must account for zinc status when interpreting activity — a free peptide preparation may be inactive until zinc is present.
| Property | Value / description |
|---|---|
| Peptide class | Zinc-dependent thymic nonapeptide |
| Sequence | Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn |
| Amino acids | 9 |
| Cofactor | Zinc (required for activity; FTS-Zn) |
| Approx. molecular weight | ≈ 857 g/mol (peptide moiety) |
| Source tissue | Thymic epithelial cells |
Mechanism of action
The active FTS-Zn complex is studied for its influence on T-lymphocyte differentiation and maturation. Thymulin is associated with promoting the acquisition of T-cell markers and functional competence as precursor cells mature within the thymic microenvironment, positioning it as part of the signaling milieu that shapes the developing T-cell repertoire.
Beyond differentiation, thymulin is studied for immunomodulatory and anti-inflammatory effects. Research has associated it with modulation of cytokine production and with effects on inflammatory and nociceptive signaling in animal models, suggesting a role in restraining excessive immune activation rather than simply stimulating it. This balancing character is a recurring theme in thymic-peptide research.
Thymulin also participates in a bidirectional thymus–neuroendocrine axis: its secretion is influenced by hormones such as growth hormone, thyroid hormones, and glucocorticoids, while thymulin in turn is studied for feedback onto neuroendocrine structures. This crosstalk is one reason it is examined alongside broader immune peptides such as Thymosin Alpha-1 and host-defense peptides like LL-37.
- Active only as the zinc-bound FTS-Zn complex.
- Associated with T-lymphocyte differentiation and maturation.
- Linked to modulation of cytokine balance and inflammation.
- Embedded in bidirectional thymus–neuroendocrine signaling.
Immune regulation research
The central research context for thymulin is immune homeostasis, particularly in settings of reduced thymic output. Because active thymulin declines with age, zinc deficiency, and certain stressors, it has been studied as a marker and potential modulator of immunosenescence — the gradual weakening and dysregulation of immune function with age. Restoring zinc in deficient research models has been associated with recovered thymulin activity and improved immune parameters.
Preclinical work has also examined thymulin in inflammatory and pain models, where it has been associated with anti-inflammatory and antinociceptive effects, and in models of infection and immune challenge. These studies frame thymulin less as a broad stimulant and more as a regulator that helps return immune signaling toward balance, consistent with its role in the thymus.
Evidence caveat
Most thymulin findings come from animal models and mechanistic studies, with limited modern controlled human data. Activity also depends on zinc status, which complicates interpretation. Findings are described here as research observations.
Comparison: Thymulin vs Thymosin Alpha-1 vs Thymalin
Thymulin is most often compared with other thymic peptides. Thymosin Alpha-1 is a well-characterized 28-residue immunomodulatory peptide, and Thymalin is a thymic peptide preparation studied in longevity and immune contexts. All derive from thymic biology but differ in structure and the specifics of their proposed action.
| Compound | Type | Defining feature | Note |
|---|---|---|---|
| Thymulin | Nonapeptide (FTS) | Zinc-dependent activity | Marker of zinc status and thymic function |
| Thymosin Alpha-1 | 28-residue peptide | Broad innate/adaptive immunomodulation | Most clinically studied thymic peptide |
| Thymalin | Thymic peptide preparation | Mixed thymic-derived peptides | Studied in immune and longevity research |
Researchers interested in thymic immunomodulation frequently examine thymulin alongside Thymosin Alpha-1. Full entries for related compounds are in the peptide database.
Half-life and pharmacokinetic considerations
As a small nonapeptide, thymulin is expected to have a short circulating half-life, on the order of minutes, owing to rapid peptidase activity. The interpretive twist unique to thymulin is that its measured activity depends on available zinc: the same amount of peptide can register as active or inactive depending on whether the metal is present to form FTS-Zn.
Because of this dual dependence on clearance and on zinc coordination, thymulin pharmacokinetics are studied in terms of the active complex rather than the peptide alone. This makes zinc status an essential variable in any thymulin experiment and a frequent confounder when comparing results across studies.
Reconstitution and handling considerations
Lyophilized thymulin is reconstituted with sterile or bacteriostatic water, added slowly down the vial wall and swirled gently rather than shaken. Because biological activity depends on zinc coordination, research handling emphasizes that the free peptide may require zinc to register activity; the reconstituted solution should be clear, and cloudiness or particulates indicate it should be discarded.
Working concentrations are selected so research volumes are convenient and reproducible. The reconstitution calculator and reconstitution guide describe the general method.
- Add diluent slowly; swirl gently rather than shaking.
- Confirm the solution is clear before use.
- Account for zinc status, since activity depends on the FTS-Zn complex.
- Protect from light and avoid repeated freeze–thaw cycles.
Storage considerations
Lyophilized thymulin is most stable frozen at −20 °C, kept dry and away from light. Once reconstituted, it is refrigerated at 2–8 °C and used within a limited window; aliquoting before freezing reduces freeze–thaw cycling, which helps preserve the small peptide's integrity.
| Form | Condition | Notes |
|---|---|---|
| Lyophilized powder | −20 °C, dark, dry | Most stable for long-term holding |
| Reconstituted solution | 2–8 °C, protected from light | Use within a limited window |
| Freeze–thaw | Avoid repeated cycles | Aliquot to minimize cycling |
Research limitations
Thymulin is a research compound whose evidence base rests largely on older immunological and animal studies, with limited modern controlled human data. Its strict zinc dependence complicates interpretation, since the same preparation may be active or inactive depending on metal availability. The thymus–neuroendocrine connections it participates in are complex and incompletely mapped. It is described here strictly for research reference.
- Activity depends on zinc, complicating cross-study comparison.
- Much evidence is from animal models and older studies.
- Modern controlled human data are limited.
- It is not an approved therapy and is described solely for research reference.
Research Use Only
This profile is for educational and laboratory reference. Thymulin is not intended for human consumption, diagnosis, treatment, or prevention of disease.
Frequently Asked Questions
What is thymulin?
Thymulin is a zinc-dependent nonapeptide (historically called facteur thymique sérique, FTS) produced by thymic epithelial cells. It is studied in immunological research for its association with T-cell differentiation and immune regulation, and it is biologically active only when bound to zinc.
Why does thymulin need zinc?
Zinc coordination induces the conformation thymulin requires for biological activity. Without bound zinc the peptide is inactive (apo-thymulin); the active form is the FTS-Zn complex, which is why zinc status is central to thymulin research.
How does thymulin affect the immune system?
Research associates the active FTS-Zn complex with T-lymphocyte differentiation and maturation, modulation of cytokine balance, and anti-inflammatory effects in animal models. It is studied as a regulator that helps balance immune signaling rather than a simple stimulant.
How is thymulin different from Thymosin Alpha-1?
Both are thymic immunomodulatory peptides, but thymulin is a short nonapeptide whose activity depends on zinc, while Thymosin Alpha-1 is a larger 28-residue peptide studied more broadly across innate and adaptive immunity and with a deeper clinical research base.
How strong is the evidence for thymulin?
The evidence is mostly preclinical and mechanistic, drawn from animal models and older immunological studies, with limited modern controlled human data. Its zinc dependence further complicates interpretation across studies.
Related Research Profiles
Thymosin Alpha-1
Thymosin Alpha-1 is a 28-amino-acid thymic peptide studied extensively in immunological research for its association with T-cell maturation, dendritic-cell activation, and Toll-like-receptor-mediated immune modulation.
Read profileLL-37
LL-37 is the only human cathelicidin antimicrobial peptide, studied in preclinical research for its association with broad host-defense activity, immune modulation, and wound-related signaling.
Read profileVIP (Vasoactive Intestinal Peptide)
VIP is a 28-amino-acid neuropeptide of the secretin/glucagon superfamily studied in preclinical research for its association with anti-inflammatory immune signaling, vasodilation, and neuroendocrine regulation.
Read profileReferences
- Dardenne M, et al. Contribution of zinc and other metals to the biological activity of the serum thymic factor (thymulin). Proc Natl Acad Sci USA. 1982.Source
- Mocchegiani E, et al. Zinc, metallothioneins and immunosenescence: thymulin and immune function in ageing. Proc Nutr Soc. 2010.
- Safieh-Garabedian B, et al. The role of the thymic peptide thymulin in inflammation and pain. Inflammation Research. 2011.
Research Use Only
For research use only. Not intended for human consumption, diagnosis, treatment, or prevention of disease. The information on this page is provided for educational and laboratory reference purposes only.
